Pillar Clinical Research Revenue and Competitors
Estimated Revenue & Valuation
- Pillar Clinical Research's estimated annual revenue is currently $5.9M per year.
- Pillar Clinical Research's estimated revenue per employee is $91,800
Employee Data
- Pillar Clinical Research has 64 Employees.
- Pillar Clinical Research grew their employee count by 56% last year.
Pillar Clinical Research Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.7M | 33 | -17% | N/A | N/A |
#2 | $5.2M | 57 | 4% | N/A | N/A |
#3 | $1.8M | 25 | -11% | N/A | N/A |
#4 | $1.7M | 24 | 9% | N/A | N/A |
#5 | $2.1M | 29 | -3% | N/A | N/A |
#6 | $1.1M | 18 | -14% | N/A | N/A |
#7 | $3M | 37 | -18% | N/A | N/A |
#8 | $6.3M | 69 | -3% | N/A | N/A |
#9 | $32.4M | 289 | 5% | N/A | N/A |
#10 | $84M | 659 | 6% | N/A | N/A |
What Is Pillar Clinical Research?
Pillar Clinical Research, LLC provides expert & experienced conduct of Phase 1-4 clinical trials for both inpatient and outpatient studies. We are a multi-specialty clinical research group, with specialization in CNS indications: such as, but not limited to, schizophrenia, mood & anxiety disorders, PTSD, post-partum depression, addictions.
keywords:N/A
N/A
Total Funding
64
Number of Employees
$5.9M
Revenue (est)
56%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pillar Clinical Research News
$20M IHMC research facility could connect Pensacola's historic and ... That new pillar would mean the staff could study things such as how...
Carbone: [Immunotherapy] represents a new pillar of therapy available for treating patients with lung cancer. It started out in the second-...
Results of the validation study of Pillar's oncoReveal Dx Lung & Colon Cancer Assay established that this FDA-approved IVD assay can...
Other Companies in Richardson
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 64 | 31% | N/A |
#2 | $19.2M | 65 | 5% | N/A |
#3 | $12.9M | 65 | 41% | N/A |
#4 | $21M | 66 | -6% | N/A |
#5 | $13.1M | 66 | -1% | N/A |